Matches in Nanopublications for { ?s ?p "[We examined whether a receptor subtype-selective inhibitor of mGluR5, AFQ056, improves the behavioral symptoms of FXS in a randomized, double-blind, two-treatment, two-period, crossover study of 30 male FXS patients aged 18 to 35 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP603073.RATXUai-FPsCGwraWR7xeiZU9_l6UFdXibSc1ZnKmEKrg130_assertion description "[We examined whether a receptor subtype-selective inhibitor of mGluR5, AFQ056, improves the behavioral symptoms of FXS in a randomized, double-blind, two-treatment, two-period, crossover study of 30 male FXS patients aged 18 to 35 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP603073.RATXUai-FPsCGwraWR7xeiZU9_l6UFdXibSc1ZnKmEKrg130_provenance.
- NP789593.RA7P5gnR8Wo2gJry_ggVsIuh11fJ2EYMoW9jRLCXCCCIk130_assertion description "[We examined whether a receptor subtype-selective inhibitor of mGluR5, AFQ056, improves the behavioral symptoms of FXS in a randomized, double-blind, two-treatment, two-period, crossover study of 30 male FXS patients aged 18 to 35 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789593.RA7P5gnR8Wo2gJry_ggVsIuh11fJ2EYMoW9jRLCXCCCIk130_provenance.